Potential of Gene Therapy Strategy for the Treatment of Hypertension
Open Access
- 1 January 2006
- journal article
- review article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 47 (1), 6-9
- https://doi.org/10.1161/01.hyp.0000196685.91424.01
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Prevention of Cardiac Hypertrophy by Angiotensin II Type-2 Receptor Gene TransferHypertension, 2004
- Gene Therapy and Heme Oxygenase Coming of AgeHypertension, 2004
- Protection From Ischemic Heart Injury by a Vigilant Heme Oxygenase-1 Plasmid SystemHypertension, 2004
- Gene Therapy With Human Tissue Kallikrein Reduces Hypertension and Hyperinsulinemia in Fructose-Induced Hypertensive RatsHypertension, 2003
- Antisense to Epidermal Growth Factor Receptor Prevents the Development of Left Ventricular HypertrophyHypertension, 2003
- Blood Pressure–Independent Attenuation of Cardiac Hypertrophy by AT 1 R-AS Gene TherapyHypertension, 2002
- Human Adrenomedullin Gene Delivery Protects against Cardiac Hypertrophy, Fibrosis, and Renal Damage in Hypertensive Dahl Salt-Sensitive RatsHuman Gene Therapy, 2000
- Human Kallikrein Gene Delivery Attenuates Hypertension, Cardiac Hypertrophy, and Renal Injury in Dahl Salt-Sensitive RatsHuman Gene Therapy, 1998
- Gene Therapy in Hypertension: Adenovirus-Mediated Kallikrein Gene Delivery in Hypertensive RatsHuman Gene Therapy, 1997
- Direct gene delivery of human tissue kallikrein reduces blood pressure in spontaneously hypertensive rats.Journal of Clinical Investigation, 1995